Bottom line
SCHLX vs LOGSX: the short answer
SCHLX (DWS Health and Wellness Fund) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 38% of their top holdings (by weight) are shared.
But SCHLX is far broader, holding 65 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
LOGSX is cheaper at 1.04% vs 1.06% — a difference of $2.00 a year per $10,000 invested.
Updated Nov 19, 2026
SCHLX vs LOGSX side by side
| SCHLX | LOGSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | DWS (Xtrackers) | Oak Associates |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.06% | 1.04% |
| Annual cost per $10k | $106 | $104 |
| 10-yr cost on $10k (prospectus) | $1,294 | $1,271 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | — |
| 1-yr return | — | +19.6% |
| 5-yr return (annualized) | — | +8.1% |
| 10-yr return (annualized) | — | +7.3% |
| Best quarter | — | +13.4% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $231.8M | $56.1M |
| Number of holdings | 65 | 28 |
| Portfolio turnover | 2% | 24% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of SCHLX's top 25 holdings also appear in LOGSX's top 25.
| Holding | SCHLX | LOGSX |
|---|---|---|
| Eli Lilly & Co | 13.85% | 1.99% |
| Johnson & Johnson | 6.19% | 3.77% |
| Merck & Co Inc | 4.85% | 3.16% |
| Novartis AG | 2.90% | 4.67% |
| Amgen Inc | 2.88% | 4.86% |
| Gilead Sciences Inc | 2.78% | 3.50% |
| Intuitive Surgical Inc | 2.69% | 2.99% |
| Vertex Pharmaceuticals Inc | 2.45% | 3.26% |
| McKesson Corp | 2.05% | 4.53% |
| Novo Nordisk A/S | 1.73% | 2.51% |
| Bristol-Myers Squibb Co | 1.50% | 4.02% |
| Regeneron Pharmaceuticals Inc | 1.43% | 4.43% |
| Cardinal Health Inc | 1.34% | 5.86% |
| Cencora Inc | 1.26% | 4.46% |
Source: SEC Form N-PORT
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
LOGSX top 10
- N/a — 6.91%
- Cardinal Health Inc — 5.86%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Exelixis Inc — 4.95%
- Amgen Inc — 4.86%
- Lantheus Holdings Inc — 4.68%
- Novartis Ag — 4.67%
- Mckesson Corp — 4.53%
- Cencora Inc — 4.46%
FAQ
What is the difference between SCHLX and LOGSX?
Which is cheaper, SCHLX or LOGSX?
Should I own both SCHLX and LOGSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.